$USPH

U.S. Physical Therapy (NYSE: USPH) lifts 2025 EBITDA and outlines hospital-driven growth

U.S. Physical Therapy (USPH) reported strong operating momentum in 2025, with adjusted EBITDA up 16.1% to $95 million, and expects 2026 adjusted EBITDA to be between $102 million and $106 million. The company achieved record clinic visit volumes despite Medicare rate cuts and saw significant growth in its injury prevention segment. USPH also announced two new long-term hospital affiliation agreements, projected to add at least $14 million to physical therapy revenue and $7.3 million to its adjusted EBITDA by 2027.

Original reporting
Published Mar 4, 2026, 9:52 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 4, 2026, 10:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
U.S. Physical Therapy (NYSE: USPH) lifts 2025 EBITDA and outlines hospital-driven growth — source image
Decision brief

The 30-second read

$USPHBullishMed
01

Why it matters

The company's expansion into hospital affiliations and record clinic visits suggest sustained growth, supporting bullish sentiment.

02

Market read

The news is relevant for traders focusing on healthcare services, with potential short to medium-term upside.

03

What to watch

Regulatory changes, reimbursement policies, and competitive pressures that may affect future performance.

Timing: Immediate (within 1 week)

Background

USPH reported strong 2025 financials with EBITDA growth and new hospital contracts, indicating operational momentum.

Company-level read

Ticker impact

$USPHBullishHigh confidence
Context

The news highlights USPH's strong 2025 performance and future growth prospects, making it relevant for traders interested in healthcare and service sector stocks.

Expected impact

Moderate upward movement (~5-8%) over the next 1-3 months, contingent on continued growth and market conditions.

Evidence & confidence

Strong financial results, new hospital contracts, and positive industry trends support an optimistic outlook. Risks include industry headwinds and potential market volatility.

Market effects

Positive impact on healthcare services and outpatient care sectors due to expansion and growth in physical therapy services.

Primarily US-based, with potential influence on regional healthcare providers and related stocks.

Limited; USPH operates mainly within the US healthcare market.

Counterpoint

Potential overestimation of growth due to optimistic projections; industry headwinds like Medicare rate cuts could impact profitability.

Key entities

  • U.S. Physical Therapy

    A provider of outpatient physical therapy services in the US.

Related articles

$USPHMed

U S PHYSICAL THERAPY INC /NV (USPH): Results of Operations and Financial Condition

U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 ex99-1.htm Exhibit 99.1 CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Second Quarter 2026 Results,

$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.

$WTRGMed

Trump administration to invest $3 billion in minerals projects to boost US defence supply chains

President Trump said the US will invest $3 billion in critical minerals and battery projects to expand domestic supply chains for national security. He announced Defence Department Office of Strategic Capital conditional loans totaling $1.4B to Sila Nanotechnologies, $400M to Sunrise Energy Metals, and $150M to Niron Magnetics, plus $58M Export-Import Bank loans. The plan also includes $100M in mining-school grants and $80M for three schools.

$NVDAMed

Nvidia to Invest Up to $3 Billion in Blackstone

The Information reported Nvidia plans to invest up to $3 billion in Lancium, a Blackstone-backed power and data center infrastructure developer tied to the Stargate AI initiative. Nvidia would initially put in $2 billion for a 20% stake, with up to $1 billion more contingent on performance thresholds. No company comment was provided.

$NVDAMed

Nvidia to invest up to US$3 billion in Stargate data centre developer Lancium: The Information

Nvidia plans to invest up to $3 billion in Lancium, the developer of the Stargate data center campus in Texas, The Information reported. Nvidia would invest $2 billion for about a 20% stake, with an additional $1 billion possible based on grid hookup thresholds. Lancium’s land and power portfolio has an enterprise value near $10 billion, and it may explore an IPO in 2027.

$USARMed

Is USA Rare Earth (USAR) Overvalued On Its DOE Funding And Tokenization Buzz?

Simply Wall St says USA Rare Earth (USAR) shares have rebounded after being selected by the U.S. Department of Energy for up to $19.3M in federal funding, pending final negotiations, for a pilot-scale rare earth separations project. The article cites mixed valuation views, with a “fair value” of $0.33 versus a DCF estimate of $83.09, and notes recent price returns.